Event Details

The SIO NCCN Task Force submitted recommendations to the NCCN for the latest revision of the Neuroendocrine Tumor treatment guidelines.  Rony Avritscher from MD Anderson Cancer Center, Nick Fidelman from UCSF, and Etay Ziv from Memorial Sloan Kettering Cancer Center authored the SIO submission.

...

The COVID-19 pandemic presents us with a crisis of significant magnitude with no clear end in sight. There are numerous stressors affecting our healthcare system, economy, and social lives. In the midst of all this, we face new challenges to our mission to advance the field of IO, particularly in re...

COVID19 poses a real threat to the well-being of our patients and we, as physician-scientists, are taking this threat seriously. In light of the available data, we act diligently to protect those most vulnerable in this situation: our cancer patients. The necessary measures to mitigate the spread of

...

Cancer care during the pandemic requires assessment of several factors that are specific to each patient as well as the curve of the pandemic in a particular location and the infrastructure capabilities at the center offering care. As a general approach, we consider continuation of cancer care unles...

The COVID-19 pandemic has greatly impacted the entire patient experience in interventional oncology at our institution.  This goes beyond the known infected patients or those under investigation with the newly expected, necessary personal protective equipment (PPE) and safety precautions taken. It a...

“Why are you bringing all these cancer patients into the hospital and putting us all at risk?” asked one of my non-IO colleagues. An undiagnosed COVID patient brought in that day for an extended procedure resulted in losing six staff to a week-long quarantine.

Treating cancer patients during the CO...

As we all struggle to provide optimal care for our patients during these unprecedented times, it is clear that the pandemic has affected us all in different ways: with differing timing, magnitude, resource constraints, and local policies.

Given these circumstances, it is difficult to develop broadl...

The Society of Interventional Oncology NCCN Committee spearheaded an effort in 2019 to provide input into the 2020 update of Kidney Cancer NCCN guidelines. SIO brought our RCC task force together and helped us through the specifics of the NCCN submission process.

...

MSK Workshop Chair, Dr. Jack Jennings of Washington University Saint Louis, shares his perspective on SIO as he leads the SIO2020 Program Committee planning of the second annual Musculoskeletal Interventional Oncology Workshop at SIO2020.

...

Dr. Suh is a clinical Professor in the Department of Radiological Sciences at the Ronald Reagan UCLA Medical Center and the David Geffen School of Medicine at UCLA. Currently, he serves as Scientific Chair on the SIO2020 Program Committee.

...